“Breast Cancer Statistics.”. Centers for Disease Control and Prevention. 2017. Available at: www.cdc.gov/cancer/breast/statistics/index.htm Accessed December15, 2017.
2.
ShapiroS, VenetW, StraxP, VenetL. Periodic screening for breast cancer, the health insurance plan project and its sequelae 1963–1986. Baltimore: Johns Hopkins University Press, 1988.
3.
TabárL, VitakB, ChenHH, et al.The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am, 2000; 38:625–651.
4.
AnderssonI, AspegrenK, JanzonL, et al.Mammographic screening and mortality from breast cancer: The Malmö mammographic screening trial. BMJ, 1988; 297:943–948.
5.
FrisellJ, EklundG, HellströmL, LidbrinkE, RutqvistLE, SomellA. Randomized study of mammography screening—Preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat, 1991; 18:49–56.
6.
FrisellJ, LidbrinkE, HellströmL, RutqvistLE. Followup after 11 years—Update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat, 1997; 45:263–270.
7.
BjurstamN, BjörneldL, WarwickJ, et al.The Gothenburg breast screening trial. Cancer, 2003; 97:2387–2396.
8.
MossSM, CuckleH, EvansA, et al.Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: A randomised controlled trial. Lancet, 2006; 368:2053–2060.
9.
AlexanderFE, AndersonTJ, BrownHK, et al.14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet, 1999; 353:1903–1908.
10.
Tilanus-LinthorstM, VerhoogL, ObdeijnIM, et al.A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer, 2002; 102:91–95.
11.
SaslowD, BoetesC, BurkeW, et al.American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin, 2007; 57:75–89.
12.
LehmanCD, IsaacsC, SchnallMD, et al.Cancer yield of mammography, MR, and US in high-risk women: Prospective multi-institution breast cancer screening study. Radiology, 2007; 244:381–388.
13.
DalyMB, AxilbundJE, BuysS, et al.Genetic/familial high-risk assessment: Breast and ovarian. J Natl Compr Canc Netw, 2010; 8:562–594.
14.
MainieroMB, LourencoA, MahoneyMC, et al.ACR appropriateness criteria breast cancer screening. J Am Coll Radiol, 2016; 13:R45–R49.
15.
WernliKJ, DeMartiniWB, IchikawaL, et al.Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med, 2014; 174:125–132.
16.
MilesR, WanF, OnegaT, et al.Underutilization of supplemental MRI screening among patients at high breast cancer risk. J Women's Health, 2018; 27:748–754.
17.
AmornsiripanitchN, ManganoM, NiellBL. Screening mammography: Patient perceptions and preferences regarding communication of estimated breast cancer risk. AJR Am J Roentgenol, 2017; 208:1163–1170.
